Abstract:We previously found that apolipoprotein E (APOE) ∊4 gene dose, reflecting three levels of genetic risk for late-onset Alzheimer's disease (AD), is associated with characteristic patterns of glucose hypometabolism and fibrillar amyloid-beta (Aβ) burden in cognitively normal older adults (Reiman et al, 2004; 2009). We have also introduced an automated algorithm, known as multi-modal partial least squares (MMPLS), to characterize the linkage between patterns in two or more complementary complex data sets from the same person on a voxel-by-voxel basis (Chen et al, 2009). In this study, we used MMPLS to characterize how APOE ∊4 gene dose is associated with patterns of cerebral hypometabolism and fibrillar Aβ burden. We investigated how metabolic and Aβ measurements, in respective clusters of preferentially affected voxels, are related to each other. MMPLS was used in “informed mode” for the simultaneous analysis of fluorodeoxyglucose (FDG) and Pittsburgh Compound B (PiB) positron emission tomography (PET) images from 11 ∊4 homozygotes, 11 ∊4 heterozygotes, and 16 ∊4 noncarriers who were cognitive normal (65 ± 5 years old). Patterns of cerebral-to-whole brain FDG PET counts and cerebral-to-cerebellar PiB Distribution Volume Ratios (DVRs) most closely associated with APOE ∊4 gene dose were characterized. ∊4 homozygote, heterozygote, and non-carrier groups did not differ significantly in their age, gender distribution, educational level, Mini-Mental State Examination scores (29.6 ± 0.8), or Auditory Verbal Learning Test long-term memory scores. Patterns most closely associated with APOE ∊4 gene dose were notable for lower glucose metabolism in the precuneus and posterior cingulate cortex and increased fibrillar Aβ in the precuneus, posterior cingulate cortex and medial prefrontal cortex. As expected, there was a strong correlation between lower cerebral glucose metabolism and higher fibrillar Aβ in respective empirically defined statistical regions-of-interest (comprised of voxels associated with ∊4 gene dose at p≤0.005) in all 38 subjects (r = -0.46, p = 0.0039) and in the 22 ∊4 carriers (r = -0.47, p = 0.028). Larger sample sizes are needed to further characterize the relationships for each APOE genotype. There is a strong relationship between the pattern of regional hypometabolism and fibrillar Aβ deposition associated with three levels of genetic risk for late-onset AD in cognitively normal adults.

APOE4 and Infectious Diseases Jointly Contribute to Brain Glucose Hypometabolism, a Biomarker of Alzheimers Pathology: New findings from the ADNI

APOE4 and Infectious Diseases Jointly Contribute to Brain Glucose Hypometabolism, a Biomarker of Alzheimer's Pathology: New Findings from the ADNI

Elevated blood glucose levels are associated with the progression of brain hypometabolism, and HDL-C and APOE4 add to this association

DECREASED INTRINSIC FUNCTIONAL NETWORK IN COGNITIVELY INTACT ELDERLY APOE-E4 CARRIERS MEASURED BY EIGENVECTOR CENTRALITY MAPPING

IC-P-060: Decreased Intrinsic Functional Network in Cognitively Intact Elderly APOE-E4 Carriers Measured by Eigenvector Centrality Mapping

Associations Between APOE Genotype and Cerebral Small-Vessel Disease: a Longitudinal Study

Affect of APOE on Information Processing Speed in Non-Demented Elderly Population: a Preliminary Structural MRI Study

APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly

IC‐P‐122: Association Between an Alzheimer's Disease‐Related Hypometabolic Convergence Index in Cognitively Normal Late‐Middle‐Aged People and Three Levels of Genetic Risk for Late‐Onset Alzheimer's Disease

Association Between Cerebral Patterns of Fibrillar Beta-Amyloid Burden and Glucose Hypometabolism in Cognitively Normal Older Adults at Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease

Modeling Spatial and Temporal Patterns of APOE ε4 Mediated Glucose Uptake in Mild Cognitive Impairment and Normal Controls

APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.

APOE, vascular pathology, and the AD brain

β-Amyloid is Associated with Aberrant Metabolic Connectivity in Subjects with Mild Cognitive Impairment

Assessment of neurovascular uncoupling: APOE status is a key driver of early metabolic and vascular dysfunction

APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction

Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum

Correlations Between Cholesterol-Related Genetic Risk Scores and Lower Brain-Imaging Measurements of Regional Glucose Metabolism

Higher Serum Glucose Levels Are Associated with Cerebral Hypometabolism in Alzheimer Regions

APOE ϵ4 modifies the relationship between infectious burden and poor cognition.

<i>APOE </i>4 modifies the relationship between infectious burden and poor cognition